Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07447050) titled 'Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: University of California, Irvine
Condition:
Breast Cancer
Sarcoma
Gastric (Stomach) Cancer
Lung Cancer
Head and Neck Cancer
Colorectal Cancer
Ovarian Cancer
Liver Cancer
Genitourinary Cancer
Gynecologic Cancer
Intervention:
Drug: Riluzole
Recruitment Status: Recruiting
Phase: Phase 2
Date of...